Skip to main content

Advertisement

Log in

Clinical and urodynamic evaluation of women referred with diabetes mellitus

  • Original Article
  • Published:
International Urogynecology Journal Aims and scope Submit manuscript

Abstract

Introduction and hypothesis

We investigated the impact of diabetes mellitus (DM) on female lower urinary tract dysfunction.

Methods

We prospectively collected data of 1,640 consecutive diabetic women from the inpatient departments and outpatient clinics of urology, endocrinology, geriatrics, and nephrology in primary, secondary, and tertiary referral hospitals, rural healthcare stations, and nursing homes in Dujiangyan, China. Clinical histories were taken on an individualized basis depending on patient presentation. Urodynamics were performed in the enrolled female diabetic patients after excluding other causes of lower urinary tract dysfunction. Data on lower urinary tract symptoms and urodynamic parameters were analyzed.

Results

Ninety-three percent of diabetic women complained of lower urinary tract symptoms, and 88 % had positive urodynamic findings. Sixty-three percent presented with storage symptoms, 918 cases of which had detrusor overactivity, 787 impaired detrusor contractility, and 131 detrusor areflexia. Among the 918 patients with impaired detrusor contractility or detrusor areflexia, the mean first sensation of filling was 238.1 ml, with a mean maximum cystometric capacity of 624 ml, mean maximum flow rate of 9.6 ml/s, mean detrusor pressure at maximum flow rate of 32.4 cmH2O, and mean postvoid residual of 323 ml. Thirty-eight of 131 patients with detrusor areflexia had impaired renal function on blood chemistry test, and massive bilateral ureterohydronephrosis and “Christmas-tree-shaped” bladder in videourodynamic studies. On the whole, 95 % diabetic women had diabetic cystopathy.

Conclusions

DM alters voiding patterns significantly, causing various lower urinary tract symptoms in a significant proportion of diabetic women. Diabetic cystopathy is a progressive condition with a spectrum of clinical symptoms and urodynamic findings. The prevalence of diabetic cystopathy is very high in Dujiangyan, China.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention

  2. Xu Y, Wang L, He J, Bi Y, Li M, Wang T, Wang L, Jiang Y, Dai M, Lu J, Xu M, Li Y, Hu N, Li J, Mi S, Chen CS, Li G, Mu Y, Zhao J, Kong L, Chen J, Lai S, Wang W, Zhao W, Ning G, 2010 China Noncommunicable Disease Surveillance Group (2013) Prevalence and control of diabetes in Chinese adults. JAMA 310(9):948–959

    Article  CAS  PubMed  Google Scholar 

  3. Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN (2010) An International Urogynecological Association IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J 21(1):5–26

    Article  PubMed  Google Scholar 

  4. Kaplan SA, Te AE, Blaivas JG (1995) Urodynamic findings in patients with diabetic cystopathy. J Urol 153(2):342–344

    Article  CAS  PubMed  Google Scholar 

  5. Sasaki K, Yoshimura N, Chancellor MB (2003) Implications of diabetes mellitus in urology. Urol Clin N Am 30(1):1–12

    Article  Google Scholar 

  6. Fayyad AM, Hill SR, Jones GR (2009) Prevalence and risk factors for bothersome lower urinary tract symptoms in women with diabetes mellitus from hospital-based diabetes clinic. Int Urogynecol J Pelvic Floor Dysfunct 20:1339–1344

    Article  PubMed  Google Scholar 

  7. Moller CF, Olesen KP (1976) Diabetic cystopathy IV: Micturition cystourethrography compared with urodynamic investigation. Dan Med Bull 23:291

    CAS  PubMed  Google Scholar 

  8. Moller CF (1976) Diabetic cystopathy III: Urinary bladder dysfunction in relation to bacteriuria. Dan Med Bull 23:287

    CAS  PubMed  Google Scholar 

  9. Lee WC, Wu HP, Tai TY, Liu SP, Chen J, Yu HJ (2004) Effects of diabetes on female voiding behavior. J Urol 172:989–992

    Article  PubMed  Google Scholar 

  10. Liu RT, Chung MS, Lee WC, Chang SW, Huang ST, Yang KD et al (2011) Prevalence of overactive bladder and associated risk factors in 1359 patients with type 2 diabetes. Urology 78:1040–1045

    Article  PubMed  Google Scholar 

  11. Lee WC (2009) The Impact of Diabetes on the Lower Urinary Tract Dysfunction. JTUA 20:155–161

    Google Scholar 

  12. American Diabetes Association (2013) Standards of medical care in diabetes—2013. Diabetes Care 36(suppl 1):S11–S66

    Article  PubMed Central  Google Scholar 

  13. Pannek J, Blok B, Castro-Diaz D, Del Popolo G, Kramer G, Radziszewski P, Reitz A, Stöhrer M, Wyndaele J-J (2013) Guidelines on Neurogenic Lower Urinary Tract Dysfunction. European Association of Urology 10

  14. Yoshimura N, Chancellor MB, Andersson KE, Christ GJ (2005) Recent advances in understanding the biology of diabetes-associated bladder complications and novel therapy. BJU Int 95:733–738

    Article  PubMed  Google Scholar 

  15. Beshay E, Carrier S (2004) Oxidative stress plays a role in diabetes-induced bladder dysfunction in a rat model. Urology 64(5):1062

    Article  PubMed  Google Scholar 

  16. Ueda T, Yoshimura N, Yoshida O (1997) Diabetic cystopathy: relationship to autonomic neuropathy detected by sympathetic skin response. J Urol 157:580–584

    Article  CAS  PubMed  Google Scholar 

  17. Knowler WC, Barrett-Connor E, Flowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393–403

    Article  CAS  PubMed  Google Scholar 

  18. Subak LL, Johnson C, Whitcomb E, Boban D, Saxton J, Brown JS (2002) Does weight loss improve incontinence in moderately obese women? Int Urogynecol J Pelvic Floor Dysfunct 13:40–43

    Article  CAS  PubMed  Google Scholar 

  19. Brown JS, Wing R, Barrett-Connor E, Nyberg LM, Kusek JW, Orchard TJ, Ma Y, Vittinghoff E, Knaya AM, Diabetes Prevention Program Research Group (2006) Lifestyle intervention is associated with lower prevalence of urinary incontinence: the Diabetes Prevention Program. Diabetes Care 29:385–390

    Article  PubMed Central  PubMed  Google Scholar 

  20. Chapple C, Khulla V, Gabriel Z, Dooley JA (2005) The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis. Eur Urol 48:5–26

    Article  CAS  PubMed  Google Scholar 

  21. Novara G, Galfano A, Secco S, D’Elia C, Cavalleri S, Ficarra V, Artibani W (2008) A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder. Eur Urol 54:740–763

    Article  CAS  PubMed  Google Scholar 

  22. Zincke H, Campbell JT, Palumbo PJ, Furlow WL (1974) Neurogenic vesical dysfunction in diabetes mellitus: another look at vesical neck Resection. J Urol 111:488–490

    CAS  PubMed  Google Scholar 

  23. Fedele D (2005) Therapy insight: sexual and bladder dysfunction associated with diabetes mellitus. Nat Clin Pract Urol 2:282–290

    Article  PubMed  Google Scholar 

  24. Daniels DH, Powell CR, Braasch MR, Kreder KJ (2010) Sacral neuromodulation in diabetic patients: success and complications in the treatment of voiding dysfunction. Neurourol Urodyn 29:578–581

    PubMed  Google Scholar 

  25. Van Kerrebroeck PE, Van Voskuilen AC, Heesakkers JP et al (2007) Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J Urol 178:2029–2034

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

I express my sincerest gratitude and appreciation to all those who gave me the opportunity to complete this study. I extend my thanks to the all doctors, faculties, and staff members in all hospitals, rural healthcare stations, nursing homes throughout Dujiangyan City, and the Dujiangyan Health Bureau for their assistance. Finally, special recognition goes to my family, especially my wife, Lei Jing, and my son, Yuan Leilei, whose support, encouragement, and patience helped me while I researched and wrote this paper.

Conflicts of interest

This study was supported by Science and Technology Department of Sichuan Province, P.R. China. We declare that we have no financial and personal relationships with people or companies that can inappropriately influence our work.

Dr. Yuan ZhengYong, Dr. He Changxiao, and Prof. Shen Hong designed the study, developed the protocol, participated in and supervised data collection, performed data analysis, and wrote the paper. Dr. Yan Shibing, Dr. Wu Caiwen, Dr. Huang Yingchuan and colleagues. participated in data collection and manuscript writing.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yuan Zhengyong.

Additional information

Dr. Yuan Zhengyong and Dr. He Changxiao contributed equally to this study.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Changxiao, H., Zhengyong, Y., Shibing, Y. et al. Clinical and urodynamic evaluation of women referred with diabetes mellitus. Int Urogynecol J 25, 979–983 (2014). https://doi.org/10.1007/s00192-014-2354-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00192-014-2354-5

Keywords

Navigation